Neoplasms
📧 Sign up to get email alerts when something new happens for Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: A Study Of PF-06263507 In Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of PF-06263507 in advanced solid tumors has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: A Study of Tafetinib in Chinese Patients With Advanced Solid Tumor [Phase 1]
Phase 1 trial assessing Tafetinib in Chinese patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: GREAT - Good Response With Appropriate Treatment
Clinical trial update for the GREAT study (NCT02293785) by Mario Negri Institute indicates a good response with appropriate treatment. The t…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: BAY1238097, First in Man [Phase 1]
Bayer's BAY1238097, a first-in-man Phase 1 trial for neoplasms, has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) [Phase 1]
Phase 1 trial of robatumumab (SCH 717454, MK-7454) in combination with different regimens in pediatric participants with advanced solid tumo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) [Phase 1, Phase 2]
Clinical trial update for robatumumab (SCH 717454, MK-7454) in combination regimens in advanced solid tumors; study terminated with results …
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain Metastases [Phase 1]
A Phase I trial evaluating the use of stereotactic radiosurgery after surgical resection for brain metastases has been completed.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)
An observational study of NeoRecormon (epoetin beta) in cancer patients with anemia has completed and posted results (FAST).
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma [Phase 4]
Phase 4 trial evaluating pegylated interferon plus ribavirin in chronic hepatitis C patients with other malignancies (not hepatocellular car…
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Asian Phase I Study Of PF-03446962 [Phase 1]
Pfizer reports results from an Asian Phase I study of PF-03446962 in neoplasms, with the trial status showing completion and results posted …
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Effect of Neomycin on the Pharmacokinetics of Regorafenib [Phase 1]
Phase 1 study assessing how neomycin affects the pharmacokinetics of regorafenib, sponsored by Bayer; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)
Clinical trial update describing a screening study to identify BRAF V600 mutation–positive patients for enrollment into Zelboraf (vemurafeni…
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome [Phase 2]
The Phase 2 trial of Everolimus for advanced malignancies in Peutz-Jeghers syndrome has been withdrawn.
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: Aging and Family Outcomes in Supportive Care of Advanced Cancer Patients [NA]
VA-sponsored clinical trial examining aging and cancer outcomes in supportive care for advanced cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2015-04-01Clinical Trial Update: SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I [Phase 3]
Phase 3 trial SHTC EUROPE-1 evaluating Synergo hyperthermia-chemotherapy for urinary bladder neoplasms has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED) [Phase 1]
This Phase 1 trial evaluates a Farnesyl Protein Transferase Inhibitor (FPTI) in combination with docetaxel for advanced solid tumors and has…
-
CLINICAL_TRIALS research · 2015-01-01Clinical Trial Update: Data Collection in Patients Undergoing CT-Guided Needle Interventions for NeedleWays System Development [NA]
This update describes data collection in patients undergoing CT-guided needle interventions for the development of the NeedleWays system.
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Advance Care Planning: A Way to Improve End-of-life Care Life Care [NA]
Update on a University of Aarhus study evaluating advance care planning to improve end-of-life care across heart failure, pulmonary disease,…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Effect of Rifampin on the Pharmacokinetics of BAY73-4506 [Phase 1]
Phase 1 trial evaluating the effect of rifampin on the pharmacokinetics of BAY73-4506 in patients with Neoplasms. The study informs potentia…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120 [Phase 1]
This clinical trial update reports results from an open-label Phase I/II extension study of BIBF 1120 (nintedanib) in patients with advanced…
-
CLINICAL_TRIALS withdrawal · 2014-11-14Clinical Trial Update: Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses [Phase 1]
Phase 1 trial of SS1(dsFv)-PE38 (SS1P) for advanced malignancies was withdrawn.
-
CLINICAL_TRIALS research · 2014-11-13Clinical Trial Update: Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients [Phase 1]
This Phase 1 trial evaluating the cardiovascular safety parameters of sorafenib (BAY 43-9006) in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance [Phase 2]
Phase 2 study evaluating glucarpidase (CPG2) for management of delayed methotrexate clearance in patients with neoplasms; the trial has comp…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib [Phase 3]
Phase 3 trial for ErbB2-overexpressing metastatic breast cancer using paclitaxel, trastuzumab, and lapatinib; study terminated with results …
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: NP2 Enkephalin For Treatment of Intractable Cancer Pain [Phase 2]
Phase 2 clinical trial evaluating NP2 Enkephalin for intractable cancer pain has completed. The study targeted patients with neoplasms.